📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mg | 90 pills | £3.12 | £400.91 £280.63 Best Price | |
| 100mg | 60 pills | £3.32 | £284.30 £199.01 | |
| 100mg | 30 pills | £4.06 | £174.09 £121.86 | |
| 200mg | 90 pills | £4.68 | £602.17 £421.52 Popular | |
| 200mg | 60 pills | £5.03 | £431.25 £301.88 | |
| 200mg | 30 pills | £6.28 | £269.93 £188.95 |
Disclaimer: This information is for patient use and should not replace medical advice from a healthcare professional. Always follow the instructions provided with the medicine or by a healthcare professional.
Utrogestan (Progesterone) is a hormone medication supplied as a progestogen product. The active ingredient is progesterone, a natural female sex hormone (hormone produced by the ovaries) that supports the lining of the uterus (endometrium) and helps regulate the menstrual cycle. The medication belongs to the progestogen class, which includes synthetic and natural forms used to modify the effects of oestrogen on the uterus. The primary therapeutic purpose is to provide progesterone supplementation when natural production is insufficient or when prescribed as part of fertility treatment or hormone support regimens.
Utrogestan is used under medical supervision and may be given in different formulations, including oral capsules or vaginal preparations. The route of administration influences how the medicine is absorbed and how it acts within the body. The product requires a healthcare professional’s prescription in many UK settings, depending on local rules and the clinical indication.
As a hormone preparation, Utrogestan should be used exactly as prescribed. Changes to dose or duration must be discussed with a clinician. Potential interactions with other medicines and conditions should be evaluated before starting therapy. If any unexpected symptoms occur, seek medical advice promptly.
It is important to store Utrogestan as directed on the packaging and to keep it out of the reach of children. If any information on the label is unclear, or if packaging is damaged, contact a pharmacist for guidance. The information provided here is intended to support, not replace, professional advice.
In the United Kingdom, access to Utrogestan may require a prescription depending on local rules and the specific indication. Always rely on the guidance given by the prescribing clinician and the official patient leaflet that accompanies the product.
Progesterone supplementation is used to support the uterine lining during certain fertility treatments and to help maintain early pregnancy when natural production is insufficient. The medicine may be prescribed for luteal phase support in assisted reproduction cycles and for progesterone deficiency-related conditions diagnosed by a clinician. Clarification about the exact indication will be provided by the prescriber and reflected in the patient information leaflet supplied with the product.
In some cases, Utrogestan is used as part of hormone support regimens for women undergoing specific fertility procedures. The aim is to create a stable hormonal environment so that the endometrium can support implantation and early pregnancy. The choice of oral versus vaginal formulation, dose, and duration are determined by the treating clinician based on the clinical context.
Effectiveness depends on correct use, timing, and continuation of therapy as prescribed. If planned pregnancy is not achieved or if pregnancy is not ongoing, clinicians may reassess the treatment plan or consider alternative options. For other indications related to progesterone deficiency, the clinical rationale will be communicated by the prescribing clinician.
Patients should not assume a therapeutic outcome without medical review. Any questions about the reason Utrogestan has been prescribed should be discussed with the healthcare professional who issued the prescription. In all cases, use should align with the official patient information leaflet and healthcare professional instructions.
For individuals using Utrogestan in conjunction with fertility treatments, it is essential to continue monitoring as advised by the clinic. Some situations require additional monitoring or adjustments to the treatment plan to optimise outcomes or manage side effects.
Begin with a review of the product form prescribed. In the UK, Utrogestan may be supplied as oral capsules or vaginal formulations. The exact instructions for administration depend on the specific presentation and indication. Follow the dosing schedule provided by the clinician and the information in the patient leaflet. If any part of the guidance is unclear, contact a pharmacist or healthcare professional for clarification.
Always check the expiry date before use and inspect the packaging for any signs of damage. Do not use if the contents appear altered or if the packaging is damaged. Utrogestan should be stored as indicated on the box or leaflet, away from heat, moisture, and direct sunlight. Keep the medication out of reach of children and never share it with others.
If a dose is missed, follow the instructions in the patient information leaflet or contact a healthcare professional for advice. Do not double up doses unless explicitly advised by a clinician. In general, do not use more than the prescribed amount or extend the duration without medical guidance.
Before starting Utrogestan, inform the prescribing clinician of all medicines being taken, including over-the-counter products, vitamins, herbal supplements, and any known allergies. Some medicines can interact with progesterone and affect how Utrogestan works. If a new medicine is started during therapy, seek advice from a pharmacist or clinician to assess for potential interactions.
Review all current medicines with a clinician or pharmacist. Provide a complete allergy history, including to progesterone or related products. Confirm whether pregnancy is a possibility and discuss any history of liver disease or blood clots, as relevant safety considerations may apply.
Follow the exact route, dose form, and schedule prescribed. Oral capsules are swallowed with a small amount of water, while vaginal formulations are inserted according to the instructions provided with the product. Do not alter the route of administration unless advised by a clinician.
Establish a regular daily routine to help adherence. Some formulations may be taken at a preferred time of day or with meals, depending on the product type and clinical indication. Do not take more or less than prescribed, and avoid skipping doses without medical guidance.
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not attempt to compensate by taking extra doses at once.
For patients undergoing assisted reproduction, treatment plans may include specific timing related to procedures or embryo transfer. Do not alter the plan without consulting the fertility team. If there are changes in rhythm or scheduling, seek guidance promptly.
Timing and food effects depend on the formulation used. Some presentations are absorbed differently when taken with food versus on an empty stomach. If the clinician has advised a specific timing, that schedule should be followed precisely. When any uncertainty exists, rely on the instructions supplied with the product and seek clarification from a pharmacist.
Regardless of form, carry and store Utrogestan as directed. If a travel plan is planned, discuss storage considerations with a pharmacist, especially for long journeys or environments with extreme temperatures. Do not transfer capsules to unapproved containers and avoid exposing the medication to heat or moisture during travel.
When the dose form is vaginal, ensure proper insertion technique as described in the leaflet. If diffusion into the vaginal area is a concern during activity or gym sessions, adjust activity plans in line with medical advice, while maintaining the treatment schedule.
It is important to report any persistent or worsening symptoms during use, and to discuss ongoing treatment with the clinician at follow-up appointments. Changes in health status, including signs of potential adverse reactions, should be communicated promptly to a healthcare professional.
Hormonal therapies typically take several days to exert noticeable effects. In some patients, improvements may begin within the first week, while others may require longer to observe changes in symptoms or clinical status. The absence of immediate effects does not always indicate a problem; monitoring and clinical assessment are used to determine response.
Common experiences during early use include changes in mood, sleep, or appetite, as well as potential transient abdominal discomfort or breast tenderness. These symptoms are not universal and may vary between individuals. If symptoms are severe or persist, contact a healthcare professional for a safety review.
In fertility-related use, the clinician may monitor pregnancy status and endometrial changes through scheduled assessments. Any concerns about pregnancy progression, vaginal bleeding, or other unusual symptoms should be reported to the healthcare team promptly. Do not rely on self-diagnosis for pregnancy status or the need for continued therapy.
Adherence remains a key factor in outcomes. If difficulties arise with taking the medication as prescribed, discuss alternatives or support strategies with a pharmacist or clinician. The aim is to maintain consistent progesterone exposure as guided by the treatment plan.
Contact a clinician promptly if there are signs of a severe allergic reaction, such as swelling of the face or throat, severe rash, or difficulty breathing. Seek urgent medical help if there are sudden chest pain, severe headaches with vision changes, or any symptoms suggesting a serious adverse reaction.
Inform the clinician if there are persistent or worsening abdominal pain, heavy vaginal bleeding (in appropriate contexts), or a high fever. If pregnancy is suspected or confirmed, medical supervision is essential to determine ongoing management and safety for both patient and fetus.
Provide a current list of all medicines, including over-the-counter products and herbal supplements, to help identify potential interactions. If planning surgery, dental procedures, or invasive tests, inform the treating team about Utrogestan use to ensure appropriate perioperative management.
In the UK context, check with a pharmacist or clinician if there is any doubt about continuing therapy during illness, especially if vomiting or severe diarrhea occurs. Certain illnesses may affect how the medicine is absorbed or tolerated, requiring a review of the treatment plan.
Store at room temperature in a dry place away from heat and light. Do not refrigerate unless the packaging specifies that refrigeration is required. Keep the product in its original packaging to protect it from moisture and to preserve label information.
Keep Utrogestan out of reach of children and pets. Do not use beyond the expiry date printed on the label. If the medicine is no longer needed or has passed the expiry date, follow local guidance for safe disposal. Do not flush medications down the toilet unless advised otherwise.
When traveling, carry the medication in its original packaging to help identify it, and protect it from high temperatures. If a refill is required while away from home, consult a local pharmacist about safe continuation and any local regulatory considerations.
For storage in shared living spaces or accommodation with limited climate control, consider portable storage options that comply with product guidelines and maintain stable conditions as advised by the manufacturer’s leaflet or a pharmacist.
Common side effects may include mild changes in mood, fatigue, breast tenderness, or abdominal discomfort. These experiences are often temporary. Seek medical advice if any symptom is persistent, severe, or affects daily functioning.
Contraindications include known severe allergy to progesterone, active liver disease, certain types of vaginal bleeding without a diagnosed cause, or a known or suspected pregnancy where Utrogestan is not indicated. The clinician will assess risk factors before initiating therapy and provide tailored guidance.
Before starting, disclose any history of blood clots, stroke, or cardiovascular disease, as well as liver or gallbladder problems. Inform about current or planned pregnancy, breastfeeding status, and all medications to assess potential interactions and safety considerations.
Emergency signs include sudden severe chest pain, shortness of breath, swelling in the legs, or an unusually severe headache with vision changes. In such cases, seek urgent medical help. Do not rely on self-care alone for these symptoms.
In the United Kingdom, Utrogestan may require a prescription depending on local rules and the clinical indication. Pharmacy staff can provide information based on the specific formulation dispensed and the accompanying leaflet. Always follow the instructions supplied with the product and the clinician’s advice.
Before traveling with Utrogestan, review local storage regulations and ensure the medication remains within its recommended environmental conditions during transit. If flying, keep the medicine in carry-on luggage where allowed, and carry the original packaging to confirm identity and contents.
When visiting dental professionals or undergoing dental procedures, inform them about Utrogestan use. Certain procedures or anaesthetic agents may interact with hormone therapy, and clinicians can adjust management accordingly to maintain safety and efficacy.
If a switch from a different progesterone product is planned, consult the prescribing clinician. Transitions between formulations may require timing adjustments or monitoring to maintain consistent progesterone exposure and treatment goals.
The following frequently asked questions address common practical concerns. The answers are cautious and are not a replacement for personalised medical advice. Always consult a healthcare professional for individual guidance.
Traveling with Utrogestan is commonly feasible, but the guidance may depend on the form and local regulations. Keeping the medication in the original packaging with clear labeling is advised. If travelling to destinations with strict rules on medicines, check with the airline or border authorities and consult a pharmacist for any required documentation.
In many cases, a single time shift does not significantly affect safety, but it may influence overall hormone exposure and treatment effectiveness. If the dose is missed or taken at an abnormal time, consult the clinician or pharmacist for advice on how to proceed.
Most patients may take commonly used non-prescription medicines alongside Utrogestan, but interactions cannot be ruled out in all cases. Inform the clinician about all medicines used, including OTC products, to assess compatibility and safety.
Switching between progesterone products can be appropriate in some circumstances, but a clinician should oversee the transition. Changes may involve adjustments to timing, dose form, or duration to maintain effective exposure and minimize adverse effects.
Onset of effect varies between individuals and indications. Some people report improvement within days to weeks, while others may require a longer period. Ongoing assessment by the clinician guides expectations and plans for continuation or adjustment.
Splitting or crushing medication is generally not recommended unless specifically advised by a clinician. Altering the dosage form can change absorption and safety. Use only the prescribed form and method of administration.
Inform the dentist about Utrogestan use, particularly if planning procedures requiring anesthesia or if there is a history of bleeding disorders or liver disease. The clinician may provide guidance on peri-procedural management or monitoring needs.
Breastfeeding safety varies with the formulation and clinical indication. If breastfeeding is ongoing or planned, discuss with a clinician to assess benefits and potential risks, and to determine whether continued use is appropriate.
If there is no improvement or if symptoms worsen, contact the prescribing clinician promptly. A review of the treatment plan, potential dose adjustments, or alternative strategies may be needed.
Maintain stable storage conditions and protect the medication from heat and moisture. Carry it in its original packaging and follow any containment or temperature recommendations provided by the manufacturer.
Illness with vomiting or significant diarrhea may affect absorption and effectiveness. Seek medical advice promptly if such symptoms occur, as temporary adjustments to administration or schedule may be considered by a clinician.
Yes. Providing the most current information about Utrogestan helps ensure safe and coordinated care. Pharmacists can offer guidance on safe alternatives or supplementary measures during urgent care visits.
Long-term safety depends on the clinical context, formulation, dose, and patient factors. A clinician will weigh benefits against potential risks and monitor accordingly. If there are concerns about long-term use, discuss them with the prescribing clinician.
Carry the prescription information, a current list of medications, and the patient information leaflet. This helps healthcare providers interpret the treatment plan and manage interactions or adverse events effectively.
Pregnancy confirmed during therapy requires medical oversight. The clinician will determine the appropriate course of action, including continuation, adjustment, or withdrawal of therapy based on prospective safety and pregnancy outcomes.
Co-administration with other hormonal therapies requires professional assessment. Some combinations may be unnecessary or contraindicated, while others can be used as part of a broader hormonal management plan. Consult a clinician to determine suitability.
Partial expulsion or reduced absorption can affect effectiveness. If this occurs, contact the clinician for advice on whether to re-dose or adjust administration. Do not double the dose without professional instruction.
14–21 days. Free from £149.08 .
5–9 days. £22.36
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
